Local Anesthesia Drugs Market To Reach $5.14 Billion By 2030

Local Anesthesia Drugs Market Growth & Trends

The global local anesthesia drugs market size is anticipated to reach USD 5.14 billion in 2030 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

 Request a free sample copy or view report summary: Local Anesthesia Drugs Market Report

Local Anesthesia Drugs Market Report Highlights

• By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period

• North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region

• Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.

Local Anesthesia Drugs Market Segmentation

Grand View Research has segmented the local anesthesia drugs market report based on drug, application, and region

Local Anesthesia Drugs Drug Outlook (Revenue, USD Million, 2018 - 2030)

• Bupivacaine

• Ropivacaine

• Lidocaine

• Chloroprocaine

• Prilocaine

• Benzocaine

• Others

Local Anesthesia Drugs Application Outlook (Revenue, USD Million, 2018 - 2030)

• Injectable

• Surface Anesthetic

Local Anesthesia Drugs Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Local Anesthesia Drugs Market

• Johnson & Johnson Services, Inc

• Pfizer Inc.

• AstraZeneca plc

• Novartis AG

• Teva Pharmaceutical Industries Ltd.

• GlaxoSmithKline plc

• Sanofi S.A.

• Merck & Co., Inc.

• Aspen Pharmacare Holdings Limited

• Mylan N.V.